1. Moon, AO, Calamia, KT, Walsh, JS. Nodular amyloidosis: review and long-term follow-up of 16 cases. Arch Dermatol. 2003;139(9):1157-1159.
Google Scholar | Crossref | Medline2. Kumakiri, M, Hashimoto, K. Histogenesis of primary localized cutaneous amyloidosis: sequential change of epidermal keratinocytes to amyloid via filamentous degeneration. J Invest Dermatol. 1979;73(2):150-162.
Google Scholar | Crossref | Medline3. Weidner, T, Illing, T, Elsner, P. Primary localized cutaneous amyloidosis: a systematic treatment review. Am J Clin Dermatol. 2017;18(5):629-642.
Google Scholar | Crossref | Medline4. Kibbi, AG, Rubeiz, NG, Zaynoun, ST, Kurban, AK. Primary localized cutaneous amyloidosis. Int J Dermatol. 1992;31(2):95-98.
Google Scholar | Crossref | Medline5. Basset, M, Hummedah, K, Kimmich, C, et al. Localized immunoglobulin light chain amyloidosis: novel insights including prognostic factors for local progression [published online ahead of print June 29, 2020]. Am J Hematol. doi:10.1002/ajh.25915.
Google Scholar | Crossref6. Wey, SJ, Chen, YM, Lai, PJ, Chen, DY. Primary Sjögren syndrome manifested as localized cutaneous nodular amyloidosis. J Clin Rheumatol. 2011;17(7):368-370.
Google Scholar | Crossref | Medline7. Fernandez-Flores, A. Cutaneous amyloidosis: a concept review. Am J Dermatopathol. 2012;34(1):1-14; quiz 15-17.
Google Scholar | Crossref | Medline8. Zhai, Z, Hao, F, Song, Z, Yang, X. Primary localized cutaneous nodular amyloidosis of the thighs. Cutis. 2015;95(6):E24-E27.
Google Scholar | Medline9. Gilbertson, JA, Theis, JD, Vrana, JA, et al. A comparison of immunohistochemistry and mass spectrometry for determining the amyloid fibril protein from formalin-fixed biopsy tissue. J Clin Pathol. 2015;68(4):314-317.
Google Scholar | Crossref | Medline | ISI10. Silverstein, SR. Primary, systemic amyloidosis and the dermatologist: where classic skin lesions may provide the clue for early diagnosis. Dermatol Online J. 2005;11(1):5.
Google Scholar | Crossref | Medline11. Kaltoft, B, Schmidt, G, Lauritzen, AF, Gimsing, P. Primary localised cutaneous amyloidosis—a systematic review. Dan Med J. 2013;60(11):A4727.
Google Scholar | Medline12. Rahman, JE, Helou, EF, Gelzer-Bell, R, et al. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol. 2004;43(3):410-415.
Google Scholar | Crossref | Medline13. Woollons, A, Black, MM. Nodular localized primary cutaneous amyloidosis: a long-term follow-up study. Br J Dermatol. 2001;145(1):105-109.
Google Scholar | Crossref | Medline14. Tong, PL, Walker, WA, Glancy, RJ, Cooney, JP, Gebauer, K. Primary localized cutaneous nodular amyloidosis successfully treated with cyclophosphamide. Australas J Dermatol. 2013;54(1):e12-e15.
Google Scholar | Crossref | Medline15. Cai, Y, Xu, S, Li, N, Li, S, Xu, G. Efficacy of chemotherapies and stem cell transplantation for systemic AL amyloidosis: a network meta-analysis. Front Pharmacol. 2019;10:1601.
Google Scholar | Crossref | Medline16. Kastritis, E, Wechalekar, AD, Dimopoulos, MA, et al. Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis. J Clin Oncol. 2010;28(6):1031-1037.
Google Scholar | Crossref | Medline17. Badar, T, D’Souza, A, Hari, P. Recent advances in understanding and treating immunoglobulin light chain amyloidosis. F1000Res. 2018;7:1348.
Google Scholar | Crossref18. Dispenzieri, A, Lacy, MQ, Zeldenrust, SR, et al. The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis. Blood. 2007;109(2):465-470.
Google Scholar | Crossref | Medline